Verizon shares inched up a modest 0.4%, closing at $44.67 with trading volume dropping 84%, as investors wondered if the ...

Redburn Atlantic trimmed Visa’s price target from $310 to $300 but kept a Neutral rating, proving that sometimes, even ...

Barclays lowered Wells Fargo’s price target from $92.00 to $87.00, though it maintained an “overweight” rating, suggesting ...

Chevron’s stock tiptoed up 0.8%, but before you celebrate with caviar, trading volume dropped a dramatic 70%—someone hit ...

Zacks Research just trimmed its FY2025 earnings forecast for AbbVie, shaving it from $12.14 to $12.02 per share. This modest ...

XTX Topco Ltd trimmed its IBM holdings by 64.5% in Q4, unloading 14,142 shares and leaving itself with 7,781 shares worth ...

Walt Disney’s stock took a modest tumble after UBS Group lowered its price target from $130 to $105, despite keeping a “buy” ...

Despite April’s stock market drama, American Express customers are still swiping like it's 2024. CEO Stephen Squeri reports ...

Ceeto Capital Group LLC pulled a Houdini, slashing its stake in ServiceNow by a dramatic 96.6%, leaving behind just 53 lonely ...

Thermo Fisher Scientific is flexing its biotech muscles in 2025, ranking third among the top healthcare stocks to watch. With ...

Morgan Stanley reduced its price target for Adobe from $600 to $510, though it maintained an “overweight” rating, still ...

Microsoft continues to be Wall Street’s software sweetheart, with Legacy Capital Wealth Partners LLC upping their stake by ...